Wang et al. observed that IL-38 gene expression was reduced in CRC tissues in comparison to healthy tissue, and high IL-38 expression in CRC biopsies was associated with prolonged survival and smaller tumor size (48), indicating that therapeutic use of recombinant IL-38 in CRC deserves investigation. This evidence concerns the gene IL1F10 and colorectal carcinoma.